Panama disease

MustGrow Reports 100% Control of Banana Disease at Economic Rates; Advancing to Field Trials in Colombia

Retrieved on: 
Tuesday, February 9, 2021
Panama disease, Cavendish banana, Tropics, Fusarium wilt, TR4, Banana, Edible plants, Tropical agriculture, Banana production, Fusarium oxysporum f.sp. cubense, Taiwan Banana Research Institute

Fusarium wilt TR4 (previously referred to as the Panama Disease) is a devastating pathogen ravaging the $25 billion global banana industry .

Key Points: 
  • Fusarium wilt TR4 (previously referred to as the Panama Disease) is a devastating pathogen ravaging the $25 billion global banana industry .
  • 100% control was achieved at economic rates as low as 5 gal/acre (49 L/ha) within a 3 day testing period.
  • Additionally, MustGrow believes its work in Colombia will serve as a beachhead to expand into other leading banana producing countries.
  • Fusarium wilt TR4 is the world's most destructive banana disease, affecting particularly Cavendish bananas, which comprise half of global banana production.

DGAP-News: MustGrow Commences Banana Panama Disease Testing in Colombia

Retrieved on: 
Tuesday, September 29, 2020
Tropical agriculture, Tropics, Cavendish banana, Panama disease, Fusarium wilt, Agriculture, TR4, Banana, Edible plants, Banana production, Taiwan Banana Research Institute, Fusarium oxysporum f.sp. cubense

Saskatoon, SK, September 29, 2020 - MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) (FRA: 0C0) (the "Company", "MustGrow") announces the commencement of testing of MustGrow's proprietary TerraMG bio-pesticide formulation on the Panama Disease (Fusarium wilt TR4), a devastating disease pathogen ravaging the $25 billion global banana industry .

Key Points: 
  • Saskatoon, SK, September 29, 2020 - MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) (FRA: 0C0) (the "Company", "MustGrow") announces the commencement of testing of MustGrow's proprietary TerraMG bio-pesticide formulation on the Panama Disease (Fusarium wilt TR4), a devastating disease pathogen ravaging the $25 billion global banana industry .
  • The laboratory testing in Colombia will focus on the treatment of the Panama Disease.
  • Panama Disease is among the most destructive banana diseases, affecting particularly Cavendish bananas, which are half of all bananas produced globally.
  • Now, MustGrow is replicating this strategy in Colombia's besieged banana industry - focused on controlling and eliminating the Panama Disease.

Rahan Meristem (1998) LTD and its Partner Banarica Report Success in Mitigating Panama Disease After Field Trials in the Philippines

Retrieved on: 
Monday, July 20, 2020
Research, Other Health, Pharmaceutical, Other Natural Resources, Oncology, Medical devices, Infectious diseases, Natural Resources, Genetics, Clinical trials, Science, Biotechnology, Health, Cavendish banana, Panama disease, Tropics, Banana, TR4, Cavendish, Domesticated plants, Edible plants, Taiwan Banana Research Institute

Rahan Meristem, with the aid of our Colombian partner Mr. Luis Alberto Restrepo President of Banarica Colombia, developed Cavendish banana plants with apparent resistance to Panama disease TR4, reports the Scientific Director Dr. Eli Khayat.

Key Points: 
  • Rahan Meristem, with the aid of our Colombian partner Mr. Luis Alberto Restrepo President of Banarica Colombia, developed Cavendish banana plants with apparent resistance to Panama disease TR4, reports the Scientific Director Dr. Eli Khayat.
  • These data corroborate the Companys earlier findings that its proprietary In-vitro mutagenesis technology is effective for creating novel traits.
  • In addition to these disease-resistance data, Rahan has previously shown both an increase in banana fruit production and improvement in plant architecture.
  • The data lead to the achievement of Rahan's R&D objective developing a "Cavendish" banana with resistance to fungal diseases.

MustGrow to Commence Work on Disease Threatening Global Banana Supply: Fusarium wilt Tropical Race 4

Retrieved on: 
Tuesday, November 12, 2019
Fusarium wilt, Fusarium oxysporum, TR4, Fusarium, Fusarium oxysporum f.sp. betae, Panama disease

SASKATOON, Saskatchewan, Nov. 12, 2019 (GLOBE NEWSWIRE) -- MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) (the "Company", "MustGrow"), an agricultural biotech company developing and commercializing a portfolio of natural, science-based bio-pesticides, is pleased to announce its intent to address a new Fusarium pathogen known as Fusarium wilt Tropical Race 4 (Fusarium wilt TR4), a soil-borne disease pathogen plaguing the global banana supply.

Key Points: 
  • SASKATOON, Saskatchewan, Nov. 12, 2019 (GLOBE NEWSWIRE) -- MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) (the "Company", "MustGrow"), an agricultural biotech company developing and commercializing a portfolio of natural, science-based bio-pesticides, is pleased to announce its intent to address a new Fusarium pathogen known as Fusarium wilt Tropical Race 4 (Fusarium wilt TR4), a soil-borne disease pathogen plaguing the global banana supply.
  • MustGrows previous independent efficacy studies involving the treatment of Fusarium oxysporum (Fusarium), a soil-borne pathogen potentially similar to Fusarium wilt TR4, have demonstrated 100% control of the fungus.
  • Its new race, Fusarium wilt TR4, has been causing serious banana losses in Southeast Asia, resulting in abandonment of thousands of hectares.
  • Fusarium wilt TR4 is among the most destructive diseases of bananas, affecting particularly Cavendish bananas, supplying around half of global banana production.